Endymed Statistics

Total Valuation

Endymed has a market cap or net worth of ILS 38.91 million. The enterprise value is 17.23 million.

Market Cap	38.91M
Enterprise Value	17.23M

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Endymed has 13.76 million shares outstanding. The number of shares has decreased by -1.66% in one year.

Current Share Class	n/a
Shares Outstanding	13.76M
Shares Change (YoY)	-1.66%
Shares Change (QoQ)	+2.05%
Owned by Insiders (%)	9.45%
Owned by Institutions (%)	0.65%
Float	5.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	0.79
P/TBV Ratio	0.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.55
EV / Sales	0.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.00

Financial Position

The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.09.

Current Ratio	4.05
Quick Ratio	2.58
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.49
Interest Coverage	-28.84

Financial Efficiency

Return on equity (ROE) is -12.84% and return on invested capital (ROIC) is -8.59%.

Return on Equity (ROE)	-12.84%
Return on Assets (ROA)	-6.78%
Return on Capital (ROIC)	-8.59%
Revenue Per Employee	1.53M
Profits Per Employee	-146,914
Employee Count	46
Asset Turnover	0.98
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.28% in the last 52 weeks. The beta is -0.34, so Endymed's price volatility has been lower than the market average.

Beta (5Y)	-0.34
52-Week Price Change	-13.28%
50-Day Moving Average	272.92
200-Day Moving Average	283.66
Relative Strength Index (RSI)	44.68
Average Volume (20 Days)	3,529

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Endymed had revenue of ILS 70.42 million and -6.76 million in losses. Loss per share was -0.49.

Revenue	70.42M
Gross Profit	32.16M
Operating Income	-7.82M
Pretax Income	-7.49M
Net Income	-6.76M
EBITDA	-7.28M
EBIT	-7.82M
Loss Per Share	-0.49

Full Income Statement

Balance Sheet

The company has 25.92 million in cash and 4.25 million in debt, giving a net cash position of 21.68 million or 1.58 per share.

Cash & Cash Equivalents	25.92M
Total Debt	4.25M
Net Cash	21.68M
Net Cash Per Share	1.58
Equity (Book Value)	49.24M
Book Value Per Share	3.58
Working Capital	42.31M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.33 million and capital expenditures -301,101, giving a free cash flow of -8.63 million.

Operating Cash Flow	-8.33M
Capital Expenditures	-301,101
Free Cash Flow	-8.63M
FCF Per Share	-0.63

Full Cash Flow Statement

Margins

Gross margin is 45.67%, with operating and profit margins of -11.11% and -9.60%.

Gross Margin	45.67%
Operating Margin	-11.11%
Pretax Margin	-10.64%
Profit Margin	-9.60%
EBITDA Margin	-10.34%
EBIT Margin	-11.11%
FCF Margin	n/a

Dividends & Yields

Endymed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.66%
Shareholder Yield	1.66%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on January 28, 2018. It was a reverse split with a ratio of 0.05.

Last Split Date	Jan 28, 2018
Split Type	Reverse
Split Ratio	0.05

Scores

Endymed has an Altman Z-Score of 2.23. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.23
Piotroski F-Score	n/a